Acticor Biotech (France) Buy Hold or Sell Recommendation
| ALACT Stock | EUR 0.25 0.00 0.00% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Acticor Biotech SAS is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Acticor Biotech SAS within the specified time frame.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. Note, we conduct extensive research on individual companies such as Acticor and provide practical buy, sell, or hold advice based on investors' constraints. Acticor Biotech SAS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Acticor |
Execute Acticor Biotech Buy or Sell Advice
The Acticor recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Acticor Biotech SAS. Macroaxis does not own or have any residual interests in Acticor Biotech SAS or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Acticor Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Acticor Biotech Trading Alerts and Improvement Suggestions
| Acticor Biotech SAS is not yet fully synchronised with the market data | |
| Acticor Biotech SAS generated a negative expected return over the last 90 days | |
| Acticor Biotech SAS has some characteristics of a very speculative penny stock | |
| Acticor Biotech SAS has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (12.61 M) with profit before overhead, payroll, taxes, and interest of 320.18 K. | |
| Acticor Biotech SAS has accumulated about 571.18 K in cash with (13.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17. |
Acticor Biotech current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Acticor analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Acticor analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Acticor Biotech Returns Distribution Density
The distribution of Acticor Biotech's historical returns is an attempt to chart the uncertainty of Acticor Biotech's future price movements. The chart of the probability distribution of Acticor Biotech daily returns describes the distribution of returns around its average expected value. We use Acticor Biotech SAS price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Acticor Biotech returns is essential to provide solid investment advice for Acticor Biotech.
| Mean Return | -0.22 | Value At Risk | 0.00 | Potential Upside | 0.00 | Standard Deviation | 1.06 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Acticor Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Acticor Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Acticor . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Acticor Biotech Buy or Sell Advice
When is the right time to buy or sell Acticor Biotech SAS? Buying financial instruments such as Acticor Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Acticor Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Information Technology ETFs Thematic Idea Now
Information Technology ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Information Technology ETFs theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Information Technology ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Acticor Stock Analysis
When running Acticor Biotech's price analysis, check to measure Acticor Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acticor Biotech is operating at the current time. Most of Acticor Biotech's value examination focuses on studying past and present price action to predict the probability of Acticor Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acticor Biotech's price. Additionally, you may evaluate how the addition of Acticor Biotech to your portfolios can decrease your overall portfolio volatility.